Enhanced pre-clinical anti-tumor activity of M7824, a novel bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
Ontology highlight
ABSTRACT: Enhanced pre-clinical anti-tumor activity of M7824, a novel bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
PROVIDER: PRJNA421428 | ENA |
REPOSITORIES: ENA
ACCESS DATA